In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies [PDF]
International Journal of Laboratory Hematology, 2016 P. Toulon +6 more
semanticscholar +2 more sources
Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis
Universa Medicina, 2016 Background Chronic hepatitis and hepatic cirrhosis are chronic liver diseases that cause disorders of liver function, such as the formation of platelets and coagulation factors (prothrombin time/PT and activated partial thromboplastin time/APTT ...
Edward Kurnia Setiawan Limijadi +2 more
doaj +3 more sources
The Thromboplastin Generation Test [PDF]
Journal of Clinical Pathology, 1953 R, BIGGS, A S, DOUGLAS
openaire +3 more sources
Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini‐review
European Journal of Haematology, 2020 A common inquiry in coagulation laboratories is how to interpret an unexpected, isolated prolonged activated partial thromboplastin time (APTT). In this context, isolated means together with a normal prothrombin time (PT) and/or normal international ...
K. Rasmussen +3 more
semanticscholar +1 more source
Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
Hepatology, EarlyView., 2022 Abstract Background and Aims Current liver‐directed gene therapies look for adeno‐associated virus (AAV) vectors with improved efficacy. With this background, capsid engineering is explored. Whereas shuffled capsid library screenings have resulted in potent liver targeting variants with one first vector in human clinical trials, modifying natural ...
Nadja Meumann +25 more
wiley +1 more source
Thromboplastin Bilbao: Reproducibility and Sensitivity of a Spanish Thromboplastin [PDF]
Pathophysiology of Haemostasis and Thrombosis, 2002 Prothrombin time (PT) is the control test for oral anticoagulant therapy as well as the screening test for defects of the extrinsic pathway of coagulation. Its responsiveness to decreased extrinsic clotting factors depends on the source and type of tissue factor thromboplastin extract. In 1994, a rabbit brain thromboplastin – Thromboplastin Bilbao (TBi)
M, Vacas +4 more
openaire +2 more sources
Timing and volume of fluid administration for patients with bleeding [PDF]
, 2003 Original article can be found at: http://www3.interscience.wiley.com Copyright John Wiley & Sons. ‘This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2003, Issue 3.
Bunn, Frances, Kwan, I., Roberts, I.
core +1 more source
Implications of deranged activated partial thromboplastin time for anaesthesia and surgery
Anaesthesia, 2018 Bleeding during and after surgery ranges from trivial to fatal. Bleeding is in part determined by the patient's coagulation status. The UK National Institute for Health and Care Excellence recommends a pre‐operative clotting test for patients with a ...
E. Loizou +3 more
semanticscholar +1 more source
Clotting Phenomena at the Blood-Polymer Interface and Development of Blood Compatible Polymeric Surfaces [PDF]
, 1972 In the past two decades many attempts have been made to relate surface and interfacial parameters with the blood compatibility of polymeric surfaces. It is however doubtful if by a single parameter the behaviour of blood on a surface can be predicted ...
Bantjes, Adriaan
core +3 more sources
Journal of Clinical Pharmacy and Therapeutics, 2016 The two most common methods for monitoring unfractionated heparin (UFH) infusion are the activated partial thromboplastin time (aPTT) and the antifactor Xa heparin assay (anti‐Xa).
Sophie Samuel +8 more
semanticscholar +1 more source